[Shanghai Daily]CanSinoBIO a step closer to becoming 3rd successful shot
CANSINO Biologics Inc’s COVID-19 vaccine showed 65.7 percent efficacy in preventing symptomatic cases and a 90.98 percent success rate in stopping severe disease in an interim analysis of global trials, Pakistan’s health minister said yesterday. The positive data moves the vaccine, jointly developed by a team led by Chen ...